ulcerative

ART trial: Adacolumn shows clinical benefit in refractory ulcerative colitis patients Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with...

Transplanted human stool may offer treatment hope for ulcerative colitis patients Patients with ulcerative colitis (UC) may improve their symptoms with a transplantation of healthy stool from donors, according to Australian researchers. The findings were presented by Dr Sudarchan Paramsothy MD...